AU8163394A - Treatment of diabetes by administration of myo-inositol - Google Patents

Treatment of diabetes by administration of myo-inositol

Info

Publication number
AU8163394A
AU8163394A AU81633/94A AU8163394A AU8163394A AU 8163394 A AU8163394 A AU 8163394A AU 81633/94 A AU81633/94 A AU 81633/94A AU 8163394 A AU8163394 A AU 8163394A AU 8163394 A AU8163394 A AU 8163394A
Authority
AU
Australia
Prior art keywords
myo
inositol
diabetes
administration
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU81633/94A
Other languages
English (en)
Inventor
Harry L. Greene
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of AU8163394A publication Critical patent/AU8163394A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A23L29/37—Sugar alcohols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/801—Peptide sweetners

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pediatric Medicine (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU81633/94A 1993-12-22 1994-12-21 Treatment of diabetes by administration of myo-inositol Abandoned AU8163394A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17381493A 1993-12-22 1993-12-22
US173814 2002-06-19

Publications (1)

Publication Number Publication Date
AU8163394A true AU8163394A (en) 1995-06-29

Family

ID=22633617

Family Applications (1)

Application Number Title Priority Date Filing Date
AU81633/94A Abandoned AU8163394A (en) 1993-12-22 1994-12-21 Treatment of diabetes by administration of myo-inositol

Country Status (6)

Country Link
US (1) US5763392A (https=)
EP (1) EP0659349A1 (https=)
JP (1) JPH07223939A (https=)
AU (1) AU8163394A (https=)
CA (1) CA2137431A1 (https=)
TW (1) TW282398B (https=)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9601395D0 (sv) * 1996-04-12 1996-04-12 Dieter Haeussinger New therapeutic treatment 1
NO301574B1 (no) * 1996-06-27 1997-11-17 Jan Oxholm Gordeladze Energidrikk
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US6080788A (en) * 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics
ATE240661T1 (de) * 1997-03-27 2003-06-15 Michael J Sole Ernährungszusammensetzung zur verbesserung der zellenenergie
ATE413889T1 (de) * 1998-06-05 2008-11-15 Nutrinia Ltd Insulin angereichertes säuglingsnährpräparat
CA2371055A1 (en) * 1999-04-27 2000-11-02 Insmed Pharmaceuticals, Inc. Compositions and methods for improving insulin sensitivity and glucose metabolism in mammals
IL134830A0 (en) * 2000-03-01 2001-05-20 Chay 13 Medical Res Group N V Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them
EP1383523B1 (de) * 2001-03-02 2006-06-07 Lichtwer Pharma AG Kombinationspräparat zur behandlung des diabetes mellitus
US20040097467A1 (en) * 2002-08-22 2004-05-20 Vijaya Juturu Arginine silicate inositol complex and use thereof
JP2004203863A (ja) * 2002-12-09 2004-07-22 Taisho Pharmaceut Co Ltd 抗糖尿病用組成物
DE10260263A1 (de) * 2002-12-20 2004-07-15 Biocrates Life Sciences Gmbh Verwendung von Tetrahydrobiopterinderivaten zur Behandlung und Ernährung von Patienten mit Aminosäurestoffwechselstörungen
PL1708690T3 (pl) 2003-11-17 2017-01-31 Biomarin Pharmaceutical Inc. Leczenie fenyloketonurii za pomocą BH4
KR20070084270A (ko) * 2004-11-17 2007-08-24 바이오마린 파머수티컬 인크. 안정한 정제 제형물
JP2006213684A (ja) * 2005-02-07 2006-08-17 Hokko Chem Ind Co Ltd インスリン抵抗性改善に用いられる組成物及び健康用食品
JP2007051132A (ja) * 2005-07-19 2007-03-01 Hokkaido Sugar Co Ltd イノシトールを成分とする食用組成物または医薬組成物
US7763650B2 (en) * 2006-03-15 2010-07-27 Medipharma S.A. Pharmaceutical compound and method
MX2010000660A (es) * 2009-12-11 2011-06-14 Abbott Lab Soluciones de rehidratacion oral que comprenden dextrosa.
ITMI20110445A1 (it) * 2011-03-22 2012-09-23 Lo Li Pharma Srl Formulazione farmaceutica comprendente inositolo.
JP5905258B2 (ja) 2011-07-01 2016-04-20 株式会社 資生堂 血小板由来成長因子−ｂｂ産生亢進剤、並びにそれを含む間葉系幹細胞産生促進剤、幹細胞安定化剤、及び真皮再生化剤
TWI582110B (zh) * 2011-07-01 2017-05-11 Shiseido Co Ltd Platelet-derived growth factor-BB produces hyperactivity agents, and is associated with leaf-derived stem cell-producing accelerators, stem cell stabilizers, and dermal regenerators
US9216178B2 (en) 2011-11-02 2015-12-22 Biomarin Pharmaceutical Inc. Dry blend formulation of tetrahydrobiopterin
US20140328970A1 (en) * 2013-05-03 2014-11-06 Mead Johnson Nutrition Company Nutritional Composition Comprising Whey and Hydrolyzed Casein and Uses Thereof
EP3177154B1 (en) * 2014-08-08 2019-09-25 Société des Produits Nestlé S.A. Myo-inositol and probiotics, and their use to prevent excess body weight in infants
EP3177277B1 (en) * 2014-08-08 2020-03-11 Société des Produits Nestlé S.A. Myo-inositol and probiotics and uses
WO2016020485A1 (en) 2014-08-08 2016-02-11 Nestec S.A. A combination of vitamin d and zinc and its use
CN107073004A (zh) 2014-08-08 2017-08-18 雀巢产品技术援助有限公司 维生素b2及其用途
WO2016020495A1 (en) * 2014-08-08 2016-02-11 Nestec S.A. Myo-inositol and one or more probiotic and use thereof
US11191735B2 (en) 2015-03-13 2021-12-07 Nutrition 21, Llc Arginine silicate for periodontal disease
US10525016B2 (en) 2015-06-03 2020-01-07 Mead Johnson Nutrition Company Nutritional compositions containing an elevated level of inositol and uses thereof
US20170135969A1 (en) 2015-11-12 2017-05-18 Jds Therapeutics, Llc Topical arginine-silicate-inositol for wound healing
GB2568849B (en) 2016-09-01 2022-08-10 Nutrition 21 Llc Magnesium biotinate compositions and methods of use
US11898184B2 (en) * 2017-09-07 2024-02-13 Sweet Sense Inc. Low glycemic sugar composition
JP2022515314A (ja) 2018-11-02 2022-02-18 ニュートリション・２１，エルエルシー イノシトール安定化アルギニンケイ酸塩複合体及びイノシトールを含有するビデオゲームプレーヤーの認知機能を改善するための組成物
GB2613672A (en) 2019-12-16 2023-06-14 Nutrition 21 Llc Methods of production of aginine-silicate complexes
CN111772022A (zh) * 2020-05-25 2020-10-16 唐传生物科技（厦门）有限公司 一种低gi健康糖及其制备方法和用途
MX2022015696A (es) * 2020-06-22 2023-01-24 Nestle Sa Composiciones que comprenden mioinositol y su uso en la prevencion de la hemorragia posparto (hpp).
CA3188423A1 (en) 2020-09-04 2022-03-10 Francois-Pierre Martin Compositions and methods for providing health benefits in an animal
WO2023183767A1 (en) * 2022-03-21 2023-09-28 Abbott Laboratories Methods and compositions for increasing insulin sensitivity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4497800A (en) * 1982-07-06 1985-02-05 Mead Johnson & Company Stable liquid diet composition
US4921877A (en) * 1986-10-27 1990-05-01 Abbott Laboratories Liquid nutritional formula for glucose intolerance
CA2047686C (en) * 1989-03-08 2000-09-05 Joseph Larner Dietary supplement for insulin-resistant diabetics
WO1991014435A1 (en) * 1990-03-19 1991-10-03 Brigham And Women's Hospital Treatment of osmotic disturbance with organic osmolytes

Also Published As

Publication number Publication date
JPH07223939A (ja) 1995-08-22
TW282398B (https=) 1996-08-01
US5763392A (en) 1998-06-09
EP0659349A1 (en) 1995-06-28
CA2137431A1 (en) 1995-06-23

Similar Documents

Publication Publication Date Title
AU8163394A (en) Treatment of diabetes by administration of myo-inositol
AU7567394A (en) Treatment chamber catheter
AU3888793A (en) Novel medicament
EP0755690A3 (en) Hypodermic cannula
AU4000293A (en) Ophthalmologic cannula
AU6623894A (en) Therapeutic compounds
AU7867994A (en) Hemofiltration of mediator-related diseases
AU3560495A (en) Medicament inhaler
AU5160796A (en) Dual action syringe
AU5383390A (en) Laparoscopy cannula
AU4941193A (en) Medical pump assembly
AU8893291A (en) Medical electrode assembly
AU1774092A (en) Self destruct double syringe
AU6425496A (en) Treatment for juvenile diabetes
AU3072989A (en) Skin treatment composition
AU3236895A (en) Aspb1 insulin analogs
AU5965696A (en) Terpenoid-type quinones for treatment of diabetes
AU6092794A (en) Oxime-substituted therapeutic compounds
AU2954692A (en) Medical preparations
AU3950193A (en) Cannula
AU1111492A (en) Method of treating type i diabetes
AU1111592A (en) Method of treating type i diabetes
AU4219793A (en) Syringe
AU7644194A (en) Diagnosis of insulin-dependent diabetes
AU3730093A (en) Methods of treating diabetes